Can blood transfusions cause acute kidney injury?

Can Blood Transfusions Cause Acute Kidney Injury?

Yes, blood transfusions can cause acute kidney injury (AKI), with the risk varying by mechanism and transfusion type, but red blood cell transfusions show the strongest independent association with AKI development.

Mechanisms of Transfusion-Associated AKI

Blood transfusions can cause AKI through multiple pathways:

Direct Hemolytic Injury

• Acute hemolytic transfusion reactions (AHTR) from ABO-incompatible blood represent the most severe mechanism, causing intravascular hemolysis and direct tubular injury that can result in prolonged renal dysfunction requiring weeks of recovery 1
• Fatal hemolysis occurs at a rate of approximately 1:1,250,000 transfused RBC units (8 per 10 million units) 2
• AHTR can cause anuric AKI requiring multiple hemodialysis sessions, with kidney function potentially taking 6+ weeks to normalize 1

Volume Overload (TACO)

• Transfusion-associated circulatory overload (TACO) occurs in 1-8% of transfused patients depending on clinical setting 2
• ICU patients receiving transfusions develop TACO at rates of 6%, with 2-3 per 100 transfused RBC units affected 2
• Volume overload can precipitate AKI through increased renal venous pressure and reduced perfusion

Non-Hemolytic Transfusion Reactions

• Any transfusion reaction increases AKI risk 2-fold (RR 2.1, p<0.02), with 25% of transfused patients experiencing some form of reaction 3
• Even mild allergic reactions (70.5% of all reactions) and febrile non-hemolytic reactions (11.6%) associate with increased AKI incidence 3
• AKI occurred in 14.7% of patients with transfusion reactions versus 7.8% without reactions 3

Red Blood Cell Transfusions: The Primary Culprit

RBC transfusions show the strongest and most consistent association with AKI across multiple clinical contexts:

Cardiac Surgery Setting

• Every unit of RBCs transfused increases the adjusted odds of developing ≥stage 2 AKI by 1.18 4
• RBC transfusion remained the only blood product independently associated with AKI after adjusting for fresh frozen plasma and platelets 5
• A dose-dependent relationship exists between RBC volume and AKI severity 5

Transcatheter Aortic Valve Replacement

• Each unit of packed RBCs transfused increases AKI odds by 1.67 (95% CI 1.13-2.47, p=0.01) after adjusting for baseline renal function and hemodynamic instability 6

Other Blood Products

• Fresh frozen plasma increases odds of ≥stage 2 AKI by 1.19 per unit transfused 4
• Platelet transfusions increase odds by 1.04 per unit 4
• However, when all blood products are analyzed together in multivariate models, only RBC transfusion maintains independent significance 5

Clinical Risk Factors

Patients at highest risk for transfusion-associated AKI include those with:

• Longer operative times (OR 1.1 per minute, p=0.03) 7
• Pre-existing renal dysfunction with elevated baseline creatinine (OR 3.8, p=0.001) 6, 7
• Advanced age and multiple comorbidities 3
• Hemodynamic instability requiring vasopressors/inotropes (OR 2.09 per agent, p=0.01) 6
• Diabetes mellitus 3

Critical Pitfalls to Avoid

Prevention Strategies

• Verify blood type compatibility meticulously before every transfusion—repeat blood type confirmation and check patient-unit compatibility to prevent catastrophic AHTR 1
• Monitor patients continuously during transfusion to recognize reactions immediately and halt transfusion at first sign of symptoms 1
• Reserve transfusions for clear indications only—liberal transfusion strategies increase AKI risk without proven benefit in most settings 3, 5

Recognition Challenges

• AKI may not manifest immediately—creatinine rises lag behind actual injury, and subclinical AKI can occur before measurable changes 8
• Transfusion reactions classified as "mild" still carry significant AKI risk 3
• The combination of transfusion with other nephrotoxic insults (contrast, medications, hypotension) compounds risk 3

Outcomes and Long-Term Implications

• Transfusion-associated AKI increases major adverse kidney events during long-term follow-up 3
• AKI persists in approximately 22.5% of affected patients, particularly those who develop complications 7
• While mortality rates may be similar between groups, the morbidity burden from prolonged renal dysfunction is substantial 3, 1